This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...